We have previously characterized a cGMP-dependent Ca 2+ -activated Cl -current in vascular smooth muscle cells (SMCs) and have shown its dependence on bestrophin-3 expression. We hypothesize that this current is important for synchronization of SMCs in the vascular wall. In the present study, we aimed to test this hypothesis by transfecting rat mesenteric small arteries in vivo with siRNA specifically targeting bestrophin-3.
Introduction
Rhythmic contractions of arteries, vasomotion, represent a synchronized activity of smooth muscle cells (SMCs) in the vessel wall. 1 Vasomotion is seen both in vivo and in vitro and has substantial cardiovascular interest for the following reasons. Studies on both animals and humans indicate a tight coupling between blood pressure level and the ability of vessels to oscillate. 2 -6 Diabetes 7 and ischaemia 8, 9 are also associated with altered prevalence of vasomotion, and there is evidence that vasomotion has a protective role during ischaemia. 8, 10 The latter suggestion is strongly supported by the finding that vasomotion enhances dialysis of the extravascular fluid. 7,11 -13 This might relate to the observation that impaired vasomotion favours the development of skin lesions and hypertension in patients with type 2-diabetes. 14 Although the reason for this is unclear, it has been shown that the insulin-mediated increase in microvascular perfusion is partially due to increased vasomotion, allowing more capillaries to be perfused per unit time. 15 Moreover, a mathematical modelling of oxygen delivery has previously suggested a positive effect of vasomotion on oxygen delivery independent of the flow 16 -18 and gained further support in an experimental animal study. 19 On this basis, it becomes important to be able to modulate vasomotion. This is only feasible if the mechanisms responsible for vasomotion are understood. We 20 . We have also demonstrated that the Cl 2 gradient is important for vasomotion. 28 We hypothesized therefore, that bestrophin-3
is important for vasomotion and performed the study to test this experimentally. 29 In the present study, we found that down-regulation of bestrophins significantly reduced the amplitude of vasomotion consistent with the prediction from reducing the Cl 2 current in our model of vasomotion. Down-regulation of bestrophin did not, however, affect the tonic responses. The findings support the suggested importance of I Cl(cGMP-Ca) for SMC synchronization.
Methods
All experiments were conducted in accordance with the European Commission Directive 86/609/EEC and after permission from the Animal Experiments Inspectorate of the Danish Ministry of Justice.
A detailed account of the Methods is provided in Supplementary material online.
Transfection
Transfection of segments of rat small mesenteric arteries in vivo was performed as described previously. 27 Wistar male rats were anaesthetized with a subcutaneous injection of a combination of 1 mg/100 g of hypnorm (fentanyl, 0315 mg/mL; fluanisone, 10 mg/mL; VetaPharma Ltd, UK) and midazolam (0.5 mg/100 g; Hameln Pharma GMBH, Germany). Supplementary anaesthesia (1/4th of the initial dose) was given each half hour during the transfection procedure. At the end of the transfection procedure and twice during the day of the surgery, a painkiller, Temgesic w (Buprenorphin, 2 mL/100 g; Schering-Plough, Belgium) was injected. Two arterial branches were transfected-one with siRNA specific for bestrophin-3 and another with the control siRNA. 27 Bestrophin-3 directed siRNA but with three mismatching nucleotides (mutated siRNA) and siRNA directed against enhanced green fluorescent protein (eGFP-siRNA) were used as the controls. 27 
Isometric myograph
Rats were sacrificed with CO 2 3 days after transfection. Mesenteric arteries were dissected out and mounted in a myograph for isometric recordings. The artery diameter was set to a value where maximal active force is obtained. Unless otherwise stated, endothelium-intact arteries were used throughout the study. In experiments with endothelium-denuded arteries, the endothelium was removed by gently rubbing the luminal surface with a hair. Successful removal was confirmed by the lack of relaxation to acetylcholine. Recorded force was converted to the wall tension by dividing the force with the double segment length. Vasomotion was analysed at the level of tone where the amplitude was highest, at 50% of maximal tone. Vasomotion amplitude was normalized to the maximal tension arterial segment developed to agonist stimulation and expressed as tension/tension max .
Confocal [Ca 21 ] i imaging
Arteries were loaded with Calcium Green-1 acetoxymethyl ester and mounted in a myograph which was placed on an inverted confocal laser scanning microscope. 20 The emission signals at 505 -530 nm (after excitation at 488 nm) were stored for analyses. 
Single-cell immunofluorescence
Second and third order branches of the mesenteric artery were dissected out, opened longitudinally, and stored overnight at 48C in a papaincontaining enzyme solution. The following day, the microtube with tissue sample was incubated for 5 min at 378C, and then single SMCs were released by trituration with a polyethylene pipette into the experimental solution. 23 Isolated SMCs from small mesenteric arteries were formaldehyde fixed and incubated with a bestrophin-3 antibody (FabGennix Inc., Frisco, TX, USA). The antibody was visualized in a confocal microscope after treatment with an Alexa-488-conjugated secondary antibody. 27 
Western blot
Cleaned pieces of arteries (two 4 mm long segments) were homogenized, and 25 mL of a protein supernatant was collected by centrifugation in concentration of 0.2 -0.7 mg/mL. Proteins were separated on gels and electrotransferred onto nitrocellulose membranes. Membranes were stained first with bestrophin-3 antibody and visualized with horseradish-peroxidase-conjugated secondary antibody. 27 The amount of bestrophin-3 was normalized to staining for pan-actin.
Immunohistochemical staining of arteries
Tissues were fixed by retrograde perfusion via the aorta, dehydrated in ethanol followed by xylene, and embedded in paraffin. The sections were dewaxed and rehydrated. The staining was carried out by incubating the sections with bestrophin-3 antibody. Labelling was visualized with 3,3'-diaminobenzidine tetrahydrochloride.
Quantitative PCR
Primers spanning different parts of the RNA of bestrophins were designed (see Supplementary material online, Table S1 ). The specific bands identified by standard reverse transcriptase PCR were isolated and sequenced (see Supplementary material online, Table S2 ). Quantitative PCR (qPCR) was carried out using Taqman probe technology. Expressions were normalized to GAPDH and transferrin receptor expressions (see Supplementary material online, Table S3 ).
Evaluation of bestrophin-3 down-regulation for intercellular coupling
Rat aortic SMCs in culture (A7r5) were transfected using the TransIT TKO transfection kit 27 with bestrophin-3 siRNA and mutated siRNA.
Seventy-four hours after transfection, pairs of A7r5 cells were used for assessment of coupling using the membrane capacitance measurements. 30 Since the membrane capacitance per area of biological membranes is nearly constant, a decrease in capacitance would reflect a reduction in membrane area. Capacitance measurements were performed using Clampex 7 (Axon Instruments Inc., CA, USA).
Data analysis
Data are presented as mean values + SEM. Significant differences between means were tested depending on the data type by paired or unpaired t-test or by unpaired one-way ANOVA followed by Bonferroni post test. P , 0.05 was considered significant, n refers to number of arteries/rats.
Mathematical modelling
To assess possible consequences of bestrophin-3 down-regulation, simulations were performed using a previously published vascular wall model.
21,22,31

Results
Immunohistochemical staining for bestrophin-3 identified bestrophin-3 in the media SMCs and in the endothelial layer ( Figure 1A ). Pre-incubation with immunizing peptide abolished all staining ( Figure 1B ). Bestrophin-3 in endothelial and SMCs was also identified using confocal imaging of whole mount staining (see Supplementary material online, Figure S1 ). In freshly isolated SMC from mesenteric small arteries, the main staining was near the cell surface ( Figure 1C) . Sometimes (20% of analysed cells), bestrophin-3 was located away from the sarcolemma (see Supplementary material online, Figure S2 ). This was mainly seen in cells with significant membrane vesiculation.
siRNA directed against bestrophin-3 (exon 10) has been chosen based on our previous study. 27 Database blasting of the siRNA sequence 32 did not reveal any significantly matching sequences in the rat genome except for the bestrophin-3 sequence. Alignment with other bestrophin genes did not identify matching sequences longer than 5-7 nucleotides. It seems unlikely that these short sequences could have siRNA action, 32 since we have shown that mutation of three nucleotides in the sequence abolished the specific of rat mesenteric small arteries in vivo with siRNA directed against bestrophin-3 (ex10-siRNA). Averaged results from qPCR experiments normalized to house-keeping genes, GAPDH, and transferrin receptor (A) (n ¼ 8) and from western blot experiments normalized to pan-actin expression (B) (n ¼ 3 -4). The expression in the different groups is normalized to the level (corresponds to 100%) in control, non-transfected artery isolated from same rats. **P , 0.01 vs. mutated siRNA.
down-regulatory action of siRNA on bestrophin-3. 27 The efficiency of in vivo transfection was assessed using Cy3-labelled siRNA (see Supplementary material online, Figure S3 ), western blotting, and qPCR ( Figure 2 and see Supplementary material online, Figure S4 ). Cy3-labelled siRNA had a perinuclear localization consistent with successful transfection 33 and similar to localization seen previously for bestrophin-3 siRNA transfection in SMC culture. 27 Western blotting demonstrated a significant reduction of bestrophin-3 by 75% after transfection with bestrophin-3-directed siRNA in comparison to arteries transfected with mutated siRNA, which had bestrophin-3 expression similar to non-transfected controls ( Figure 2B and see Supplementary material online, Figure S4 ). This was consistent with significant reduction in bestrophin-3 mRNA (Figure 2A) . Expression of other members of the bestrophin family, bestrophin-1 and -2, was identified in rat mesenteric small arteries and verified by sequencing (see Supplementary material online, Table S2 ). Fragments of bestrophin-4 mRNA were also detected, although we failed to sequence bestrophin-4 fragments larger than 195 nucleotides. Down-regulation of bestrophin-3 (ex10-siRNA) was accompanied with a reduction in mRNA expression of bestrophin-1 and -2 (see Supplementary material online, Figure S5A ). To test whether this effect is secondary to the specific downregulation of bestrophin-3, we repeated in vivo transfections with siRNA directed against another exon (exon 7) of the bestrophin-3 gene. 27 This ex7-siRNA also significantly down-regulated bestrophin-3 (44 + 14% of non-transfected artery level, n ¼ 4) when compared with the arteries transfected with non-related siRNA (eGFP-siRNA; 110 + 35% of non-transfected artery level, n ¼ 4). Similar to the effect observed with ex10-siRNA (see Supplementary material online, Figure S5A ), ex7-siRNA transfection also induced down-regulation of bestrophin-1 and -2 (see Supplementary material online, Figure S5B ).
Neither transfection with specific siRNA nor mutated siRNA affected the artery diameters ( Table 1) . Nor were there any differences in sensitivity to norepinephrine (NE ; Table 1) , and no significant differences in maximal force development (see Supplementary material online, Figure S6 ). Also relaxation to acetylcholine was unaffected by the transfection ( Table 1) .
Arteries stimulated with intermediate concentrations of NE developed vasomotion (see Supplementary material online, Figure  S7 ). We compared vasomotion in different groups at 50% of maximal tone where vasomotion has maximal amplitude. 20 The amplitude of vasomotion was reduced after transfection ( Figure 3) . The amplitude was significantly smaller in arteries transfected with the bestrophin-3-directed siRNA when compared with arteries transfected with mutated siRNA ( Figure 3B ). In contrast, the frequency of vasomotion was not significantly different between the groups ( Figure 3C ). It has previously been shown that vasomotion in rat mesenteric small arteries is endothelium-dependent. 20,34 -37 No differences in the sensitivity or maximal force development to NE were seen between the arteries from the three experimental groups after removal of the endothelium (see Supplementary material online, Figure S6B ). The removal of endothelium inhibited vasomotion at all NE concentrations. Addition of 8Br-cGMP in increasing concentrations caused the reappearance of vasomotion in all three groups of arteries, but the amplitude remained significantly smaller for the arteries transfected with bestrophin-3-directed siRNA compared with the other two groups (Figure 4) . There was no difference in the frequencies (see Supplementary material online, Figure S8 ) between the groups. Table S4 ), suggesting that siRNA transfection and downregulation for bestrophins do not affect electrical coupling between the cells. As a positive control, 100 mmoL/L 18b-glycyrrhetinic acid was shown to significantly reduce coupling (see Supplementary material online, Table S4 ).
Arteries stimulated with arginine-vasopressin (AVP) developed vasomotion of similar frequency and amplitude to the NE-induced vasomotion, although it was often more irregular (see Supplementary material online, Figure S9 ). The down-regulation of bestrophins abolished vasomotion in three out of five experiments and significantly reduced the amplitude in the other two down-regulated arteries (see Supplementary material online, Figure S9B and C) without affecting frequency (see Supplementary material online, Figure S9D ). In spite of a significant effect on oscillation in tone, down-regulation of bestrophins did not change the sensitivity or tonic contraction to AVP (see Supplementary material online, Figure S9A) .
Previously, we have modelled the generation of vasomotion.
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I Cl(cGMP-Ca) is a key element in this model for SMC synchronization. 21, 22, 31 Gradual reduction of the conductance of the bestrophin-associated Cl 2 current in the model, reduced the degree of SMC synchronization and hence, as shown in Figure 6 , the amplitude of the average [Ca 2+ ] i oscillations. This occurred both with high ( Figure 6 left column of traces) and low (right column of traces) intercellular coupling mimicking endothelium-intact arteries and endothelium-denuded arteries treated with 8-Br-cGMP, respectively 31 . Reducing I Cl(cGMP-Ca) by 75% (in accordance with the experimentally observed bestrophin-3 protein down-regulation) caused the disappearance of any synchronized oscillations (not shown). The modelling also suggested that low intercellular coupling, is in all cases associated with a higher degree of de-synchronization and hence lower oscillation amplitude. In accordance with the experimental observations, the Ca 
Discussion
The present study demonstrates a link between bestrophins and vasomotion. We have previously demonstrated the association between bestrophin-3 and I Cl(cGMP-Ca) in SMCs 27 and suggested that the bestrophin-3-associated I Cl(cGMP-Ca) is important for entrainment of SMCs of small mesenteric arteries, which is necessary for vasomotion to occur. This, however, requires experimental verification, 29 which is provided by the current findings demonstrating reduced synchronization and impaired vasomotion after knockdown of bestrophin-3. The experimental data also indicate that the bestrophin-3 associated I Cl(cGMP-Ca) is not important for the tonic contractile responses. The observed change in the expression of other bestrophin family members, which is secondary to bestrophin-3 down-regulation, complicates the analysis by making it difficult to isolate the role of bestrophin-3 from that of bestrophin-1 and -2.
We have previously demonstrated expression of bestrophin-3 in rat mesenteric small arteries 27 based on PCR and western blotting.
Here, we confirm this by immunohistochemistry of the vascular wall and demonstrate that bestrophin-3 is located in SMCs and in endothelial cells (ECs; Figure 1A , see Supplementary material online, Figure S1 ). The function of bestrophin-3 in ECs is unclear. No changes in endothelium-dependent relaxation to acetylcholine were detected in arteries down-regulated for bestrophin-3. Importantly, the reduction in the amplitude of vasomotion after down-regulation of bestrophin-3 was also seen in arteries where the endothelium was removed and vasomotion induced with 8Br-cGMP present. 20, 28, 34 This indicates that the endothelium is not important for the effect.
In isolated SMCs, we found that bestrophin-3 is localized near the sarcolemma ( Figure 1C ) in accordance with its suggested function as an ion channel. 38 In 20% of cells, we found bestrophin-3 located away from the sarcolemma. The reason for these different patterns is unclear, but since the intracellular staining was seen in SMCs with membrane vesiculation, this could reflect removal of bestrophin-3 from the membrane in SMCs undergoing apoptosis. 39 For bestrophin-1 and -2, only a fraction appears near the cell membrane, 40, 41 but also exclusive membrane-near localization of bestrophin-1 has been reported. 42 It has also been suggested that bestrophins are located to the endoplasmic reticulum where they provide counter-current necessary for Ca 2+ release. 40, 41 This Ca 2+ release might lead to activation of a cell membrane Cl 2 conductance mediated by a TMEM16 protein family member. 43 Our previous result, showing that bestrophin-3-associated I Cl(cGMP-Ca) can be evoked by sustained elevation of [Ca 2+ ] i independently from the sarcoplasmic reticulum, 23, 27 indicates that under our experimental conditions bestrophin-3 has another function. Previously, we have used qPCR and immunohistochemistry to validate the efficiency of siRNA-induced bestrophin-3 knockdown. 27 This was confirmed in the present study by qPCR and western blotting. We detected in rat mesenteric small arteries at least three members of the bestrophin family at the mRNA level. Bestrophin is associated with vasomotion expressed in the same SMC 23, 24 and only one of these Cl 2 currents has been shown to be associated with bestrophin-3. The other, 'classical' Ca 2+ -activated Cl 2 current is not affected by down-regulation of bestrophin-3 in vivo. 27 In this study, we found that mRNA of all three bestrophins is reduced in the arteries down-regulated for bestrophin-3. This together with our previous results suggest that none of the bestrophins are important for the classical Ca 2+ -activated Cl 2 conductance. The findings, however, complicate the conclusion regarding the importance of bestrophin-3 for the I Cl(cGMP-Ca) . 27 It is now necessary to find out which of the bestrophins or potential combination of them are important for the current and whether they form a multimeric channel.
38,44
Reduction of bestrophin-1 and -2 expression was achieved with two siRNA's targeting different exons of the bestrophin-3 gene. When siRNA with three mismatching nucleotides was used, none of the bestrophin isoforms were affected. Since two to three mismatching nucleotides eliminate the specific siRNA action, while offtarget effects are maintained, 32 these observations strongly suggest that the specific down-regulation of bestrophin-3 induces secondary reduction of bestrophin-1 and -2 expression. A similar phenomenon of cross-interaction at the expression level was previously described for e.g. caveolins-1 and -2 45 and connexins-37 and -40. 46 We have previously detected bestrophin-1, -2, and -3 in cultured rat SMCs (the A7r5 cell line), but in those experiments, we have not observed any changes in bestrophin-1 and -2 expression after siRNA induced down-regulation of bestrophin-3. 27 The reason for this discrepancy remains to be examined and could represent a difference between the in situ preparation used here and cultured cells. To our knowledge, this is the first experimental demonstration of close interaction between different bestrophins at the expression level. In spite of these complications, it seems that I Cl(cGMP-Ca) is important for vasomotion and depends on bestrophin-3 expression. The fourth member of the bestrophin family, bestrophin-4, has previously been suggested to be a pseudo-gene in the mouse genome 47 and its expression has never been studied in rat tissue. We were able to detect one short fragment of the bestrophin-4 mRNA, but failed to detect any longer fragments. Whether this means that bestrophin-4 is also a pseudo-gene in the rat remains to be elucidated.
The present study further demonstrated that the transfection procedure does not affect the artery diameter ( Table 1) . Some reduction in the amplitude of vasomotion of the arteries transfected with the mutated siRNA suggests some unspecific effects of the operation. 31, 34 To test that the 'remaining' vasomotion after bestrophins down-regulation had similar characteristics as the control vasomotion, we tested the effect of removal of the endothelium and application of the membrane permeable analogue 8Br-cGMP. After removal of the endothelium, the lack of vasomotion suggested that the 'remaining' vasomotion also was endothelial-dependent. Furthermore, the induction of a reduced vasomotion with 8Br-cGMP, further supports the conclusion that the 'remaining' vasomotion has qualities similar to vasomotion in control arteries. These findings strongly support our hypothesis that I Cl(cGMP-Ca) is important for synchronization. Furthermore, together with the observation that the relaxation to acetylcholine was unaffected by knockdown of bestrophins, the desynchronizing effect of knockdown appears independent of the endothelium and a role for bestrophins in SMC, therefore, seems very likely. we tested how partial reduction of I Cl(cGMP-Ca) might affect vasomotion. Even slight reduction ( 25%) of the Cl 2 conductance reduced synchronization and islands of synchronized SMC appeared similar to the experimental observations. The appearance of partial synchronization (islands) resulted in the occurrence of beat phenomena in the whole-vessel traces ( Figure 6) . A similar beating phenomenon was observed experimentally with bestrophins down-regulated arteries ( Figure 3) . Beat patterns have also been observed in endothelium-denuded arteries stimulated with intermediate concentrations of 8Br-cGMP and result from out-of-phase contractions in different parts of the vessel. 34 In line with previous simulations 21, 22 and with the present experiments, the reduction of I Cl(cGMP-Ca) and the consequent desynchronization was associated with a shift in Ca 2+ dynamics from global oscillations to waves confirming this signalling mode in asynchronous SMCs. Also consistent with the experimental observation, the frequency was unaffected by reduction of I Cl(cGMP-Ca) . Thus, the experiments using in vivo down-regulation of bestrophins support our hypothesis of a key role for the I Cl(cGMP-Ca) for initiation of vasomotion. The results also indicate that the bestrophin-3-associated I Cl(cGMP-Ca) is not essential for the tonic contractile response of rat mesenteric arteries. Future studies need to define whether the TMEM16 proteins, recently suggested to be the Ca 2+ -activated Cl 2 channel, are also important for the Cl 2 conductances and vasomotion.
Perspectives
The prevalence of vasomotion is altered in several cardiovascular conditions 1 . Vasomotion has been suggested to be important for enhancing effective tissue perfusion under certain conditions. 10, 11 Knowledge of the mechanisms responsible for initiation and control of vasomotion could be beneficial for improving blood pressure control 2, 54 and optimizing tissue-capillary fluid exchange in diabetic neuropathy and ischaemia. 7 -12 The lack of molecular understanding of the components important for the generation of vasomotion slows down the development of tools for its manipulation. The current study provides evidence that bestrophins are playing an essential role for vasomotion in rat mesenteric small arteries. Taken together, with the previously shown association of bestrophins and the Ca 2+ -activated Cl 2 conductances, bestrophins are a potential target for pharmacological interventions. Manipulations affecting this specific Cl 2 current could be beneficial for pathological conditions where efficient tissue perfusion is critical.
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